Salt Lake City – The Firm represented Techcyte, Inc. in a technology transfer and investment transaction with Mayo Clinic. Techcyte develops clinical pathology AI platforms that integrate clinical workflows with standardized infrastructure, data schema, and technical expertise. The transaction closed December 22, 2023. This was the second 2023 transaction between Mayo and Techcyte in which the Firm has advised Techcyte.
Dentons Durham Jones Pinegar shareholders Jeff Jones (Corporate), Elisabeth Calvert (Corporate) and Tadiana Jones (IP/Licensing) led the transaction for Techcyte.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
